genOway Société anonyme (EPA:ALGEN)

genOway Société anonyme Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	22.06	21.54	18.36	15.79	12.83
Other Revenue	-	4.97	2.73	4	3.49
Revenue	22.06	26.51	21.09	19.79	16.31
Revenue Growth (YoY)	-16.79%	25.70%	6.58%	21.30%	14.26%
Cost of Revenue	-	10.67	9.3	9.39	7.33
Gross Profit	22.06	15.84	11.79	10.4	8.98
Selling, General & Admin	-	9.2	8.04	8.22	7.16
Other Operating Expenses	20.25	0.82	0.75	0.95	0.87
Operating Expenses	20.25	14.27	11.3	11.1	9.32
Operating Income	1.81	1.57	0.49	-0.7	-0.34
Interest Expense	-	-0.11	-0.12	-0.27	-0.17
Interest & Investment Income	0.15	0.02	0	0.25	0.1
Currency Exchange Gain (Loss)	-	0.09	0.14	-	-
Other Non Operating Income (Expenses)	0	0.01	-0.16	-	-
EBT Excluding Unusual Items	1.96	1.58	0.35	-0.72	-0.42
Gain (Loss) on Sale of Investments	-	-0.03	-0.04	-	-
Other Unusual Items	0.31	0	0.45	0.37	-0.19
Pretax Income	2.27	1.55	0.76	-0.35	-0.61
Income Tax Expense	0.43	-0.02	-0.02	-0.03	0.08
Net Income	1.83	1.57	0.78	-0.32	-0.69
Net Income to Common	1.83	1.57	0.78	-0.32	-0.69
Net Income Growth	16.80%	101.55%	-	-	-
Gross Margin	100.00%	59.74%	55.92%	52.56%	55.07%
Operating Margin	8.21%	5.90%	2.32%	-3.53%	-2.08%
Profit Margin	8.30%	5.91%	3.69%	-1.63%	-4.21%
EBITDA	-	5.81	3.01	0.52	0.88
EBITDA Margin	-	21.93%	14.25%	2.64%	5.40%
D&A For EBITDA	-	4.25	2.52	1.22	1.22
EBIT	1.81	1.57	0.49	-0.7	-0.34
EBIT Margin	8.21%	5.90%	2.32%	-3.53%	-2.08%
Effective Tax Rate	19.16%	-	-	-	-
Revenue as Reported	-	26.59	21.4	19.8	16.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.